NCT05602493View on ClinicalTrials.gov

A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 22, 2022

Primary Completion Date

October 20, 2024

Study Completion Date

October 20, 2024

Conditions
Bone Loss, Alveolar
Interventions
DRUG

Soludronate®

In the first visit, the randomized process will take place. Tooth extraction procedure will be performed.

DRUG

sterile saline

sterile saline

Trial Locations (1)

08195

Universitat Internacional de Catalunya, Sant Cugat del Vallès

All Listed Sponsors
lead

Xeolas Pharmaceuticals Limited

INDUSTRY